| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Clinical Microbiology, September 2007, p. 3077-3081, Vol. 45, No. 9
0095-1137/07/$08.00+0 doi:10.1128/JCM.00111-07
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Unité Hépatites Virales, Laboratoire de Virologie, Hôpital Lapeyronie,1 Service de Médecine Interne E,2 Institut des Maladies de l'Appareil Digestif, Hôpital Saint-Eloi,3 Département de l'Informatique Médicale Hôpital Arnaud de Villeneuve, CHU de Montpellier, France4
Received 16 January 2007/ Returned for modification 3 May 2007/ Accepted 11 June 2007
The VERSANT HCV RNA 3.0 (bDNA), COBAS AmpliPrep/COBAS TaqMan HCV, and Abbott ART HCV RealTime assays were compared for hepatitis C virus RNA quantification in 158 clinical specimens (genotypes 1 to 5). RNA values differed significantly between methods (P < 0.0001), and mean titer differences ranged from 0.01 to 0.50 log10 IU/ml depending on the genotypes.
Published ahead of print on 20 June 2007.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|